Low toxicity and high anticancer efficacy of a novel vitamin E ether analog in preclinical prostate cancer animal models

被引：0
|
作者：
Yeh, Shuyuan
Ni, Jing
Messing, Edward M.
Chemler, Sherry
James, Nadine S.
Chen, Ming
Hsu, Iawen
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60649-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 19 条
  • [1] In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-α-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer
    Ni, Jing
    Mai, Tiejun
    Pang, See-Tong
    Haque, Imranul
    Huang, Kaohsing
    DiMaggio, Matthew A.
    Xie, Shaozhen
    James, Nadine S.
    Kasi, Dhanalakshmi
    Chemler, Sherry R.
    Yeh, Shuyuan
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 898 - 906
  • [2] A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models
    Ripsman, David
    Fergusson, Dean A.
    Montroy, Joshua
    Auer, Rebecca C.
    Huang, Johnny W.
    Dobriyal, Aditi
    Wesch, Neil
    Carrier, Marc
    Lalu, Manoj M.
    THROMBOSIS RESEARCH, 2020, 195 : 103 - 113
  • [3] A NOVEL TOPICAL RETINOID, 4-ACETAMIDOPHENYL RETINOATE, WITH HIGH EFFICACY AND LOW TOXICITY IN ANIMAL-MODELS
    CHEN, S
    TRAMPOSCH, KM
    NAIR, X
    GENDIMENICO, GJ
    TETRAULT, GB
    KISS, I
    WHITING, G
    BONNEY, RJ
    CLINICAL RESEARCH, 1992, 40 (02): : A532 - A532
  • [4] A NOVEL TOPICAL RETINOID, 4-ACETAMIDOPHENYL RETINOATE, WITH HIGH EFFICACY AND LOW TOXICITY IN ANIMAL-MODELS
    CHEN, S
    TRAMPOSCH, KM
    NAIR, X
    GENDIMENICO, GJ
    TETRAULT, GB
    KISS, I
    WHITING, G
    BONNEY, RJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 560 - 560
  • [5] In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity
    Wang, Yancai
    Ma, Yingying
    Zheng, Ying
    Song, Ju
    Yang, Xiao
    Bi, Chao
    Zhang, Dianrui
    Zhang, Qiang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 441 (1-2) : 728 - 735
  • [6] High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer
    Fizazi, K
    Sikes, CR
    Kim, J
    Yang, J
    Martinez, LA
    Olive, MC
    Logothetis, CJ
    Navone, NM
    ANTICANCER RESEARCH, 2004, 24 (5A) : 2897 - 2903
  • [7] Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
    Toren, Paul J.
    Kim, Soojin
    Pham, Steven
    Mangalji, Azzra
    Adomat, Hans
    Guns, Emma S. Tomlinson
    Zoubeidi, Amina
    Moore, William
    Gleave, Martin E.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (01) : 59 - 69
  • [8] Preclinical Efficacy and Toxicology Studies of APR-246, a Novel Anticancer Compound Currently In Clinical Trials for Refractory Hematological Malignancies and Prostate Cancer.
    Mohell, Nina
    Liljebris, Charlotta
    Alfredsson, Jessica
    Lindman, Ylva
    Uustalu, Maria
    Uhlin, Thomas
    Linderholm, Mats R. H.
    Wiman, Klas G.
    BLOOD, 2010, 116 (21) : 754 - 755
  • [9] High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models
    Marques, Rute B.
    Aghai, Ashraf
    de Ridder, Corrina M. A.
    Stuurman, Debra
    Hoeben, Sander
    Boer, Agnes
    Ellston, Rebecca P.
    Barry, Simon T.
    Davies, Barry R.
    Trapman, Jan
    van Weerden, Wytske M.
    EUROPEAN UROLOGY, 2015, 67 (06) : 1177 - 1185
  • [10] Novel tumor microenvironment ameliorator E7130 shows substantial combination efficacy with enzalutamide in a preclinical model of castration-resistant prostate cancer
    Abe, T.
    Ito, K.
    Benzaid, I.
    de Boisferon, M. H.
    Kishi, Y.
    Littlefield, B. A.
    Asano, O.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S81 - S82
12